Multiagent concurrent chemoradiotherapy (MACCRT) and gefitinib in locoregionally advanced head and neck squamous cell cancer (HNSCC).
暂无分享,去创建一个
L. Rybicki | J. Saxton | D. Adelstein | C. Rodriguez | R. Lorenz | J. Scharpf | B. Wood | D. Ives | W. Lee